ReviewTherapeutic innovation & regulatory science2026
Regulatory Alignment on Surrogate Endpoints for Slowly Progressive Ultra-Rare Neurological Diseases: Bridging the Gap Between Biomarker Science and Global Regulatory Acceptance.
Shihshuan Fang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.